Kopran P/B Ratio
Kopran (KOPRAN) P/B ratio is 1.53 (Moderate), book value per share ₹110.42 vs Healthcare average P/B of -0.33 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see KOPRAN share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
KOPRAN P/B Ratio — Valuation Insights & Book Value Analysis
Kopran price-to-book ratio interpretation, valuation status and historical context — current P/B 1.53 (Moderate). Compare with KOPRAN fundamental valuation to assess whether the stock is under or overvalued.
- Trading at premium to sector average PB of -0.33
Kopran P/B Ratio Historical Trend
KOPRAN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View KOPRAN 52-week chart for the annual high/low range and current price position.
KOPRAN Historical P/B Ratio — Book Value Per Share & Year-End Price
Kopran annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.75 | ₹110.42 | ₹193.58 | ₹530 | Moderate |
| 2025 | 1.39 | ₹107.92 | ₹150.43 | ₹518 | Moderate |
| 2024 | 2.07 | ₹102.29 | ₹211.78 | ₹491 | Moderate |
| 2023 | 2.64 | ₹91.46 | ₹241.25 | ₹439 | Moderate |
| 2022 | 1.7 | ₹88.75 | ₹150.85 | ₹426 | Moderate |
KOPRAN vs Healthcare Peers — P/B Ratio Comparison
Kopran P/B 1.53 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |